Spotlight Medical Raises $6.7M to Advance AI-powered Prognosis Tests to Clinics - Next Digital Health

Spotlight Medical, a precision medicine tech startup focusing on solving the problem of inadequate cancer therapy, has secured €6.2 ($6.75m) in seed funding to advance its first AI-based prognosis test to the market for cancer clinics. Co-founded in 2024 by Sylvain Berlemont, Marvin Lerousseau, and Grégoire Gessain, the startup’s seed funding round was led by Kurma Spotlight Medical will use the additional funding to commercialize its first AI-based test for clinical use.
read more..